Kanga Rani Selvaduray Selected Research

Tocotrienols

1/2022	Tocotrienols protect differentiated SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cytotoxicity by ameliorating dopamine biosynthesis and dopamine receptor D2 gene expression.
1/2017	Effect of palm-based tocotrienols and tocopherol mixture supplementation on platelet aggregation in subjects with metabolic syndrome: a randomised controlled trial.
1/2012	Tocotrienols and breast cancer: the evidence to date.
1/2012	Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells.
1/2011	Tocotrienol-treated MCF-7 human breast cancer cells show down-regulation of API5 and up-regulation of MIG6 genes.
12/2010	Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA.
1/2010	Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial.
1/2009	Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis.
1/2007	Tocotrienol levels in adipose tissue of benign and malignant breast lumps in patients in Malaysia.
12/2004	Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kanga Rani Selvaduray Research Topics

Disease

11	Breast Neoplasms (Breast Cancer) 11/2021 - 06/2002
6	Neoplasms (Cancer) 07/2021 - 05/2004
1	Overweight 05/2022
1	Malnutrition (Nutritional Deficiencies) 05/2022
1	Vitamin A Deficiency 05/2022
1	Neuroblastoma 01/2022
1	Drug-Related Side Effects and Adverse Reactions 11/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2010
1	Carcinogenesis 06/2002

Drug/Important Bio-Agent (IBA)

11	TocotrienolsIBA 01/2022 - 05/2004
5	Palm OilIBA 11/2021 - 06/2002
4	Vitamin E FDA LinkGeneric 01/2011 - 05/2004
3	Estrogens (Estrogen)FDA Link 01/2012 - 05/2004
2	Tamoxifen FDA LinkGeneric 01/2012 - 01/2010
2	Complementary DNA (cDNA)IBA 12/2004 - 05/2004
1	Vitamin A (Retinol)FDA LinkGeneric 05/2022
1	C-Reactive ProteinIBA 05/2022
1	MicronutrientsIBA 05/2022
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 05/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	H-cadherin (T-cadherin)IBA 07/2021
1	plastochromanol 8IBA 07/2021
1	Tocopherols (Tocopherol)IBA 01/2017
1	Cathepsin DIBA 01/2012
1	Protein Isoforms (Isoforms)IBA 01/2012
1	Messenger RNA (mRNA)IBA 12/2010
1	CytokinesIBA 12/2010
1	interleukin-24 (ST16)IBA 12/2010
1	Estrogen ReceptorsIBA 01/2010
1	alpha-Tocopherol FDA Link 01/2007
1	RNA (Ribonucleic Acid)IBA 12/2004
1	InterferonsIBA 05/2004
1	Carotenoids (Carotene)IBA 06/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2019
1	Therapeutics 01/2010
1	Biological Therapy 06/2002